87 related articles for article (PubMed ID: 16127625)
1. Prostate cancer, biological therapy, signal transduction inhibitors and anti-angiogenesis agents.
McKinnon C
IDrugs; 1999 Jul; 2(7):624-8. PubMed ID: 16127625
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy and immunotherapy.
McKinnon C
IDrugs; 1999 Jul; 2(7):620-3. PubMed ID: 16127624
[TBL] [Abstract][Full Text] [Related]
3. New drugs in prostate cancer.
Armstrong AJ; Carducci MA
Curr Opin Urol; 2006 May; 16(3):138-45. PubMed ID: 16679849
[TBL] [Abstract][Full Text] [Related]
4. Current status of anti-angiogenesis therapy for prostate cancer.
Jiménez JA; Kao C; Raikwar S; Gardner TA
Urol Oncol; 2006; 24(3):260-8. PubMed ID: 16678061
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of signal transduction protein kinases as targets for cancer therapy.
Mikalsen T; Gerits N; Moens U
Biotechnol Annu Rev; 2006; 12():153-223. PubMed ID: 17045195
[TBL] [Abstract][Full Text] [Related]
6. Targeting angiogenesis in lung cancer.
Sandler AB
Semin Oncol; 2005 Dec; 32(6 Suppl 10):S16-22. PubMed ID: 16459175
[TBL] [Abstract][Full Text] [Related]
7. New approaches in metastatic melanoma: biological and molecular targeted therapies.
Lejeune FJ; Rimoldi D; Speiser D
Expert Rev Anticancer Ther; 2007 May; 7(5):701-13. PubMed ID: 17492933
[TBL] [Abstract][Full Text] [Related]
8. [Hypoxia-inducible factor 1 and prostate cancer].
Pan ZH; Chen ZD
Zhonghua Nan Ke Xue; 2007 Apr; 13(4):356-9. PubMed ID: 17491274
[TBL] [Abstract][Full Text] [Related]
9. Translation of recent advances and discoveries in molecular biology and immunology in the diagnosis and treatment of pancreatic cancer.
Albo D; Farrow B; Berger DH
Surg Oncol Clin N Am; 2008 Apr; 17(2):357-76, ix. PubMed ID: 18375357
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer: history and rationale.
Ryan CJ; Lin AM; Small EJ
Urol Oncol; 2006; 24(3):250-3. PubMed ID: 16678059
[TBL] [Abstract][Full Text] [Related]
11. Thyroid cancer molecular signaling pathways and use of targeted therapy.
Kundra P; Burman KD
Endocrinol Metab Clin North Am; 2007 Sep; 36(3):839-53, viii. PubMed ID: 17673131
[TBL] [Abstract][Full Text] [Related]
12. Combining molecular therapeutics with radiotherapy for head and neck cancer.
Riesterer O; Milas L; Ang KK
J Surg Oncol; 2008 Jun; 97(8):708-11. PubMed ID: 18493923
[TBL] [Abstract][Full Text] [Related]
13. Small-molecule and antibody approaches to molecular chemotherapy of primary brain tumors.
Newton HB
Curr Opin Investig Drugs; 2007 Dec; 8(12):1009-21. PubMed ID: 18058572
[TBL] [Abstract][Full Text] [Related]
14. Tumor inflammatory angiogenesis and its chemoprevention.
Albini A; Tosetti F; Benelli R; Noonan DM
Cancer Res; 2005 Dec; 65(23):10637-41. PubMed ID: 16322203
[TBL] [Abstract][Full Text] [Related]
15. Novel and emerging therapies for asthma.
Leath TM; Singla M; Peters SP
Drug Discov Today; 2005 Dec; 10(23-24):1647-55. PubMed ID: 16376825
[TBL] [Abstract][Full Text] [Related]
16. Combinatorial androgen receptor targeted therapy for prostate cancer.
Singh P; Uzgare A; Litvinov I; Denmeade SR; Isaacs JT
Endocr Relat Cancer; 2006 Sep; 13(3):653-66. PubMed ID: 16954423
[TBL] [Abstract][Full Text] [Related]
17. Target-based therapies in breast cancer: current status and future perspectives.
Normanno N; Morabito A; De Luca A; Piccirillo MC; Gallo M; Maiello MR; Perrone F
Endocr Relat Cancer; 2009 Sep; 16(3):675-702. PubMed ID: 19525314
[TBL] [Abstract][Full Text] [Related]
18. Biologic therapy of breast cancer: focus on co-inhibition of endocrine and angiogenesis pathways.
Roy V; Perez EA
Breast Cancer Res Treat; 2009 Jul; 116(1):31-8. PubMed ID: 19101790
[TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic drugs: from bench to clinical trials.
Quesada AR; Muñoz-Chápuli R; Medina MA
Med Res Rev; 2006 Jul; 26(4):483-530. PubMed ID: 16652370
[TBL] [Abstract][Full Text] [Related]
20. Targeting histone deacetylases for the treatment of cancer and inflammatory diseases.
Huang L
J Cell Physiol; 2006 Dec; 209(3):611-6. PubMed ID: 17001696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
